Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - loratadine, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: sucralose; disodium edetate; maltitol solution; purified water; propylene glycol; sorbitol solution (70 per cent) (non-crystallising); glycerol; phosphoric acid; monobasic sodium phosphate monohydrate; sodium benzoate; flavour - for use in children 1-12 years for the relief of symptoms associated with allergic rhinitis such as sneezing, nasal discharge and itching, and ocular itching and burning and for the relief of symptoms and signs of allergic skin disease.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - loratadine, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: propylene glycol; citric acid monohydrate; glycerol; sodium benzoate; sucrose; purified water; flavour - for the symptomatic relief of allergic rhinitis and allergic skin disease in adults, adolescents and children aged 1 year and over.

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - loratadine, quantity: 1 mg/ml - oral liquid, solution - excipient ingredients: citric acid; propylene glycol; purified water; glycerol; sucrose; sodium benzoate; flavour - for use in children 1-12 years for the relief of symptoms associated with allergic rhinitis such as sneezing, nasal discharge and itching, and ocular itching and burning and for the relief of symptoms and signs of allergic skin disease.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

schering-plough a division of schering-plough animal health limited - loratadine 1 mg/ml - syrup - 1 mg/ml - active: loratadine 1 mg/ml excipient: citric acid monohydrate glycerol peach flavour 22935 propylene glycol purified water sodium benzoate sucrose

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

multichem nz limited - loratadine 1 mg/ml;  ;   - syrup - 1 mg/ml - active: loratadine 1 mg/ml     excipient: citric acid monohydrate glycerol peach flavour la 02495 propylene glycol purified water sodium benzoate sucrose

Kanāda - angļu - Health Canada

schering-plough canada inc - loratadine - syrup - 1mg - loratadine 1mg - second generation antihistamines

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

avkare - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

bryant ranch prepack - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2) ]. pregnancy category c: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, desloratadine should be used during pregnancy only if clearly needed. desloratadine was not teratogenic in rats or rabbits at a

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

belcher pharmaceuticals,llc - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

medispec (m) sdn.bhd - desloratadine -